A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

Huntington’s disease poses a threat to the brain—the core governing system of sensation, intellectual ability, nerve-related ...

These changes to the vasculature were ... Nov. 8, 2023 — Huntington's disease causes involuntary movements and dementia, has no cure, and is fatal. Scientists have now shown they can slow its ...

In Huntington's disease, the mutant huntingtin gene (HTT ... As the disease advances, uncoordinated, jerky body movements become more apparent, along with a decline in mental abilities and ...

potentially providing targets for preventive Huntington's disease therapies. Dopamine signaling in the striatum of the brain plays a major role in controlling voluntary movement, learning ...

Huntington’s Disease is a fatal genetic disorder that ... a hard time thinking through problems or experiencing involuntary ...

In patients with Huntington’s disease, proteins misfold and clump together. Researchers imagine the treatment could potentially someday be administered as a once-weekly injection to delay disease ...

The Phase II DIMENSION study of Sage's dalzanemdor failed to meet its primary and secondary endpoints for treating Huntington ...

Huntington's disease is an inherited condition that causes ... such as abnormal, involuntary movements. The researchers found mice lacking normal iSPN function due to disrupted TrkB signalling ...

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington's disease, an incurable, debilitating illness that causes nerve ...